Consulting Reports
New OHE Consulting Report on Shaping Research Agenda to Estimate Cost-effectiveness Thresholds for Decision Making
18 April 2016
OHE publishes new Consulting Report on shaping the research agenda to estimate relevant cost-effectiveness thresholds for Health Technology Assessment decision making.
Just Published: OHE Report on Trends in Scottish Medicines Committee Advice Decisions
25 February 2016
An analysis in the trends in Scottish Medicines Committee (SMC) advice decisions for medicines for the period October 2009 to September 2015 has just been published…
How to Manage Data Governance in an Era of Real World Evidence (RWE): Working Towards a Set of International Standards
24 November 2015
A new OHE Consulting Report assesses information governance arrangements for real-world data in eight countries, and makes recommendations towards an ideal governance framework.
Assessing the Use of Multi-indication Medicines: A Review of Current Data Capabilities in the UK
31 March 2015
A new OHE Consulting Report considers the data capabilities in the UK for monitoring medicine use according to indication using real world data.
Do Respondents Completing Abstract, Hypothetical Priority-Setting Exercises Agree with the Policy Implications of Their Choices?
3 March 2015
A new OHE Consulting Report examines whether respondents completing abstract, hypothetical priority-setting exercises in stated preference studies agree with the policy implications of their choices.
Recently Published: New Report Comparing Usage of Medicines in the UK with Other Countries
6 January 2015
September 2014 ABPI report of OHE analysis: UK use of medicines compared with other countries – UK remains 9th highest user out of 13 countries.
Cost Savings from Treating Obstructive Sleep Apnoea: OHE Consulting Report
26 September 2014
The British Lung Foundation commissioned OHE Consulting to undertake an analysis of the costs of obstructive sleep apnoea and the economic benefits of treating it. The…
OHE Consulting Report on the Trajectory of Dementia in the UK
19 June 2014
Alzheimer’s Research UK commissioned OHE Consulting to model the growing prevalence and costs of dementia in the UK and the impact that new treatments could have…
The Expanding Value Footprint of Oncology Treatments
13 May 2014
A new OHE Consulting Report examines the importance and history of HTA evaluations for additional uses for cancer drugs after their initial approval. The potential value…